Eli Lilly & Co. (LLY)
1073.29
-3.90
(-0.36%)
USD |
NYSE |
Jan 14, 16:00
1070.00
-3.29
(-0.31%)
Pre-Market: 20:00
Eli Lilly SG&A Expense (TTM): 10.39B for Sept. 30, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Amgen, Inc. | 6.976B |
| Regeneron Pharmaceuticals, Inc. | 2.717B |
| Adverum Biotechnologies, Inc. | 59.84M |
| Viking Therapeutics, Inc. | 52.36M |
| Moderna, Inc. | 1.061B |